TY  - JOUR

T1  - Inflammatory and metabolic gene signatures predict overall survival and response to venetoclax-based therapy in TP53 mutant AML

JO  - Blood

UR  - https://doi.org/10.1182/blood-2025-1734

PY  - 2025/11/03

AU  - Skuli S

AU  - Vadakekolathu J

AU  - Fenu E

AU  - Bennett K

AU  - Palma J

AU  - Harris J

AU  - Leung O

AU  - Balar E

AU  - Pozdnyakova O

AU  - Bagg A

AU  - Matthews A et al

ED  - 

DO  - DOI: 10.1182/blood-2025-1734

PB  - American Society of Hematology

VL  - 146

IS  - Supplement 1

SP  - 1734

EP  - 1734

Y2  - 2026/02/25

ER  -